Recent PPI controversy unwarranted, but long-term use should still be monitored — 4 insights

A study published in Current Opinions Gastroenterology examined the recent research on adverse effects attributed to proton pump inhibitors, Medscape reports.

Advertisement

Here’s what you should know:

1. Several studies have attributed long-term PPI use to chronic kidney disease, cognitive decline, myocardial infarction, stroke, bone fracture and even death.

2. Researchers have now found the evidence underlying those studies was very low quality, meaning the studies cannot determine cause and effect.

3. Researchers debunked the claims of adverse effects because the unintended consequences of the study have impacted PPI prescription rates.

4. Researchers did note long-term PPI use should be for the lowest effective dose and periodically reassessed.

More articles on gastroenterology:
Women’s Choice Award names 6 best endoscopy centers
Ohio-based ASC hosts 100th total joint replacement: 4 key notes
3 key strategies to developing & managing ASCs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • OSF HealthCare Saint Anthony Medical Center in Rockford, Ill., has added Tarik Firozi, MD, according to an April 6 report…

  • Miami-based Gastro Health has finalized a partnership with Digestive Disease Physicians, an Alexandria, Va.-based gastroenterology practice, according to an April…

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

Advertisement

Comments are closed.